Development of a novel RNA-based fibroblast growth factor receptor response signature (FGFR-PRS) for use in patients with urothelial cancer (UC). - Kirk L. Pappan; Gregory Mayhew; James M. Davison; Yoichiro Shibata; Joel Robert Eisner; Kirk Beebe; Michael Vance Milburn (Journal of Clinical Oncology, 2024)